Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020

Data findings on pregnant and nonpregnant women with laboratory-confirmed SARS-CoV-2 infection and found that pregnant women are more likely admitted to an intensive care unit admission and to receive mechanical ventilation.

Frontiers Susceptibility to COVID-19 in Pregnancy, Labor, and Postpartum Period: Immune System, Vertical Transmission, and Breastfeeding

PDF) Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020

Infection with SARS-CoV-2 during pregnancy and risk of stillbirth: a Scandinavian registry study

Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy

Is pregnancy a risk factor for in‐hospital mortality in

Changes in rates of adverse pregnancy outcomes during the COVID-19 pandemic: a cross-sectional study in the United States, 2019–2020

Exclusion of Reproductive-aged Women in COVID-19 Vaccination and

Frontiers COVID-19 vaccine uptake and associated factors among pregnant women attending antenatal care in Debre Tabor public health institutions: A cross-sectional study

PDF) Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020

Rapid improvement of a critically ill obstetric patient with SARS

Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study - ScienceDirect

The association between maternal characteristics and SARS-CoV-2 in pregnancy: a population-based registry study in Sweden and Norway

SARS-CoV-2 vaccination elicits broad and potent antibody effector